# Insempra

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/insempra

- Industry: Biotechnology
- Headquarters: Planegg, Germany
- Website: www.insempra.bio
- Total disclosed funding: $20M
- Latest round: Series A (Jun 14, 2023)
- Investors on record: 8

## About

Based in Planegg, Germany, and founded in 2021 by co-founder and CEO Jens Klein, Imsempra GmbH, a.k.a. Imsempra operates as a biotechnology-powered company that enables companies to use nature to create better products for beauty, personal care, food, nutrition, fiber, and performance materials. In June 2023, Imsempra GmbH raised USD 20 million in a Series A funding led by EQT Ventures, with participation from Henkel dx Ventures, By Capital, Notorious OU, Possible Ventures, Acequia Capital, Bayern Kapital, and Alante Capital. The series A funding values Imsempra GmbH at USD 69.13 million post-money.

The company provides bio-designed ingredients with lipids, natural fragrances, antioxidants, and preservatives for beauty and personal care applications. Imsempra also offers sustainable specialty health oils, natural antioxidants, and flavors for food and nutrition applications.

The company plans to use its proceeds from June 2023 funding to progress the creation of bio-based compounds for the next generation.

## Funding rounds

- Series A, Jun 14, 2023, $20M — EQT, Bayern Kapital, Acequia Capital, BlueYard Capital, Alante Capital, Possible Ventures, Skaala Investments OÜ, Henkel dx Ventures

## Investors

- EQT (https://capitalatlas.ai/funds/eqt) — Series A
- Bayern Kapital (https://capitalatlas.ai/funds/bayern-kapital) — Series A
- Acequia Capital (https://capitalatlas.ai/funds/acequia-capital) — Series A
- BlueYard Capital (https://capitalatlas.ai/funds/blueyard-capital) — Series A
- Alante Capital (https://capitalatlas.ai/funds/alante-capital) — Series A
- Possible Ventures — Series A
- Skaala Investments OÜ — Series A
- Henkel dx Ventures (https://capitalatlas.ai/funds/henkel-dx-ventures) — Series A